Americans seeking Eli Lilly and Novo Nordisk's weight-loss drugs turn to compounded market

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked in traditional channels. Americans ... Read more

Bron:

Fast Company

Tags: Novo Nordisk, Eli Lilly

Geplaatst: 04 Nov 2024 - 20:00

Related articles:

Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried? (Fool.com: The Motley Fool)
Eli Lilly Has a Major Problem With Its Weight Loss Drugs Zepbound and Mounjaro (Futurism)
Prescriptions for weight loss drugs rise 40% in the Netherlands (DutchNews.nl)
Smoothie King launches special menu for Ozempic users: 'Thoughtful balance' (NY Post: National News)